LACC1
Basic information
Region (hg38): 13:43879284-43893932
Previous symbols: [ "C13orf31" ]
Links
Phenotypes
GenCC
Source:
- juvenile arthritis due to defect in LACC1 (Limited), mode of inheritance: AR
- juvenile arthritis due to defect in LACC1 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Juvenile arthritis | AR | Allergy/Immunology/Infectious; Oncologic | Individuals have been described as benefiting from specific medications (with non-efficacy of other medications), and knowledge may help with medication selection; The condition may involve increased risk of malignancy, and awareness may allow prompt diagnosis and management; BMT has been described | Allergy/Immunology/Infectious; Oncologic | 25220867; 27881174; 29717096; 30872671 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
- Juvenile arthritis due to defect in LACC1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LACC1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 23 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 2 | 1 | 23 | 4 | 2 |
Variants in LACC1
This is a list of pathogenic ClinVar variants found in the LACC1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-43880988-G-A | Juvenile arthritis due to defect in LACC1 | Pathogenic (Feb 29, 2020) | ||
13-43881097-A-G | Benign/Likely benign (Jun 01, 2023) | |||
13-43881098-A-G | Inborn genetic diseases | Uncertain significance (Nov 17, 2023) | ||
13-43881104-A-C | Inborn genetic diseases | Uncertain significance (Oct 06, 2022) | ||
13-43881111-CTG-C | Juvenile arthritis due to defect in LACC1 | Pathogenic (Nov 30, 2021) | ||
13-43881157-C-A | Inborn genetic diseases | Uncertain significance (Apr 17, 2023) | ||
13-43881160-G-C | Inborn genetic diseases | Uncertain significance (Mar 07, 2023) | ||
13-43881199-C-A | Inborn genetic diseases | Uncertain significance (Dec 07, 2021) | ||
13-43881238-G-A | Inborn genetic diseases | Uncertain significance (Oct 06, 2021) | ||
13-43881250-T-TATACC | Juvenile arthritis due to defect in LACC1 | Likely pathogenic (Sep 10, 2020) | ||
13-43881274-GA-G | Pathogenic (Jun 30, 2022) | |||
13-43881307-C-G | Likely benign (Apr 01, 2022) | |||
13-43881340-A-G | Inborn genetic diseases | Uncertain significance (Mar 30, 2024) | ||
13-43881344-A-C | Uncertain significance (Oct 01, 2022) | |||
13-43881344-A-G | Inborn genetic diseases | Uncertain significance (Dec 08, 2023) | ||
13-43881368-A-G | Inborn genetic diseases | Uncertain significance (May 13, 2024) | ||
13-43881408-G-A | Likely benign (May 19, 2018) | |||
13-43881422-C-A | Inborn genetic diseases | Uncertain significance (Apr 08, 2022) | ||
13-43881422-C-G | Inborn genetic diseases | Uncertain significance (Jul 15, 2021) | ||
13-43881467-A-C | Inborn genetic diseases | Uncertain significance (Feb 05, 2024) | ||
13-43881476-T-G | Inborn genetic diseases | Uncertain significance (Dec 19, 2023) | ||
13-43881488-T-C | Inborn genetic diseases | Uncertain significance (Nov 12, 2021) | ||
13-43881490-A-G | Inborn genetic diseases | Uncertain significance (Apr 22, 2022) | ||
13-43881536-C-G | Inborn genetic diseases | Uncertain significance (Dec 16, 2021) | ||
13-43882311-G-A | Inborn genetic diseases | Uncertain significance (Dec 28, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LACC1 | protein_coding | protein_coding | ENST00000441843 | 5 | 14649 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000117 | 0.831 | 125696 | 0 | 37 | 125733 | 0.000147 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.64 | 157 | 226 | 0.693 | 0.0000107 | 2854 |
Missense in Polyphen | 30 | 57.459 | 0.52212 | 731 | ||
Synonymous | 0.234 | 74 | 76.6 | 0.966 | 0.00000369 | 819 |
Loss of Function | 1.35 | 10 | 15.8 | 0.634 | 8.24e-7 | 205 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000868 | 0.0000868 |
Ashkenazi Jewish | 0.00119 | 0.00119 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000418 | 0.000416 |
European (Non-Finnish) | 0.0000974 | 0.0000967 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Central regulator of the metabolic function and bioenergetic state of macrophages. In macrophages, promotes flux through de novo lipogenesis to concomitantly drive high levels of both fatty-acid oxidation and glycolysis. {ECO:0000250|UniProtKB:Q8BZT9}.;
- Disease
- DISEASE: Rheumatoid arthritis systemic juvenile (RASJ) [MIM:604302]: An inflammatory articular disorder with systemic- onset beginning before the age of 16. It represents a subgroup of juvenile arthritis associated with severe extraarticular features and occasionally fatal complications. During active phases of the disorder, patients display a typical daily spiking fever, an evanescent macular rash, lymphadenopathy, hepatosplenomegaly, serositis, myalgia and arthritis. {ECO:0000269|PubMed:25220867}. Note=The gene represented in this entry may be involved in disease pathogenesis.;
Recessive Scores
- pRec
- 0.0899
Intolerance Scores
- loftool
- rvis_EVS
- 0.02
- rvis_percentile_EVS
- 55.45
Haploinsufficiency Scores
- pHI
- 0.153
- hipred
- N
- hipred_score
- 0.261
- ghis
- 0.475
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lacc1
- Phenotype
- hematopoietic system phenotype; homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype;
Gene ontology
- Biological process
- Cellular component
- peroxisome
- Molecular function
- copper ion binding;protein binding